Please Join Us For Codexis, Inc. (CDXS) Fireside Chat | TODAY June 16 at 1:00 PM ET

Research evidence excerpt

Please Join Us For Codexis, Inc. (CDXS) Fireside Chat | TODAY June 16 at 1:00 PM ET

Biotechnology

Codexis, Inc. (CDXS)

EQUITY RESEARCH Company Update

June 16, 2026

Please Join Us For Codexis, Inc. (CDXS) Fireside Chat | Price: $2.49

Price Target: $11.00 TODAY June 16 at 1:00 PM ET

Rating: Overweight

Codexis, Inc. (CDXS; $251M Mkt. Cap)

Key Statistics: Cantor Host: Kristen Kluska, Biotechnology Analyst Symbol NASDAQ: CDXS

52-Week Range 0.96 - 3.87 June 16th

Market Cap 226.3 1:00 PM ET

ADV (3 mo) 1,934,206

Free Float (%) 6.104 Fireside Chat

Shares Out (M) 90.9 Virtual

Register

Research Analysts:

Participating Management Kristen Kluska

212-915-1927 Art Levin, PhD, Strategic Advisory Board Member

Kristen.Kluska@cantor.com

This event is for Institutional Clients of Cantor Only Ross Fladeland

212-915-1803 - Please contact your Cantor Sales Rep if interested!

ross.fladeland@cantor.com Discussion Topics

Ayan Hussein, PhD

212-915-1122 ●Taking a few steps back to understand and appreciate the technical

Ayan.Hussein@cantor.com complexities involved in RNA therapeutic manufacturing

●What promise and potential does the field of oligonucleotides hold? REV ($M)

●Big picture how might an enzymatic solution be able to address the FYE Dec 2025A 2026E 2027E

1Q $7.5 $15.2A $17.4 growing next-generation RNA therapeutics pipeline?

2Q $15.3 $15.9E $19.1

3Q $8.6 $21.2E $22.6 Speaker Biography

4Q $38.9 $23.4E $27.8 Art Levin, PhD, is a current member of Codexis’ Strategic Advisory Board Year $70.4 $75.8E $87.0

(SAB). In addition to his role on the Board of Directors, Dr. Levin previously

EPS held the positions of Distinguished Scientist, Strategic Leader and Chief

FYE Dec 2025A 2026E 2027E Scientific Officer at Avidity. Dr. Levin is a highly regarded key opinion

1Q $(0.25) $(0.10)A $(0.12)